Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody (FITC)

Este producto es parte de HEXA - Beta-Hexosaminidase Subunit Alpha
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx334834

Description

HEXA Antibody (FITC) is a Rabbit Polyclonal against HEXA.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Beta-Hexosaminidase Subunit Alpha (HEXA)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P06865
Gene ID
3073
Alias
N-acetyl-beta-glucosaminidase subunit alpha,TSD
Background
Antibody anti-HEXA
Status
RUO

Descripción

HEXA is the alpha subunit of the beta-hexosaminidase enzyme, a lysosomal hydrolase that catalyzes the breakdown of GM2 gangliosides into GM3 in the process of glycosphingolipid degradation The enzyme functions as a heterodimer composed of alpha and beta subunits, encoded by the HEXA and HEXB genes respectively Mutations in HEXA lead to Tay-Sachs disease, an autosomal recessive lysosomal storage disorder characterized by the accumulation of GM2 gangliosides in neuronal cells, resulting in neurodegeneration, progressive motor weakness, and developmental delay HEXA is highly active in neuronal tissues where glycosphingolipid metabolism is critical for normal brain function The absence or dysfunction of HEXA causes a loss of enzymatic activity leading to cellular toxicity and apoptosis Current therapeutic approaches include enzyme replacement therapy, substrate reduction therapy, and gene therapy to restore HEXA activity and slow disease progression

Related Products

abx256113

Rat Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit

Rat Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Rat beta hexosaminidase A concentrations in tissue homogenates, cell lysates and other biological fluids.

Ver Producto
abx512150

Cow Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit

Cow Beta-Hexosaminidase Subunit Alpha (HEXA) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Cow Beta-hexosaminidase subunit alpha concentrations in tissue homogenates, cell lysates and other biological fluids.

Ver Producto
abx691409

Human Beta-Hexosaminidase Subunit Alpha (HEXA) Protein (Active)

Human Hexosaminidase A Protein is a recombinant protein from Human produced in Baculovirus-Insect Cells. A DNA sequence encoding the human HEXA (AAD13932.1) (Met 1-Thr 529) was fused with a polyhistidine tag at the C-terminus.

Ver Producto